FMED | IBB | FMED / IBB | |
Gain YTD | -2.052 | 2.580 | -80% |
Net Assets | 53.7M | 5.53B | 1% |
Total Expense Ratio | 0.50 | 0.45 | 111% |
Turnover | 33.00 | 18.00 | 183% |
Yield | 0.47 | 0.30 | 154% |
Fund Existence | 5 years | 24 years | - |
FMED | IBB | |
---|---|---|
RSI ODDS (%) | N/A | 3 days ago90% |
Stochastic ODDS (%) | 3 days ago84% | 3 days ago90% |
Momentum ODDS (%) | 3 days ago84% | 3 days ago85% |
MACD ODDS (%) | 3 days ago75% | 3 days ago83% |
TrendWeek ODDS (%) | 3 days ago79% | 3 days ago84% |
TrendMonth ODDS (%) | 3 days ago81% | 3 days ago85% |
Advances ODDS (%) | 5 days ago81% | 3 days ago86% |
Declines ODDS (%) | 7 days ago79% | 7 days ago85% |
BollingerBands ODDS (%) | N/A | 3 days ago90% |
Aroon ODDS (%) | 4 days ago84% | 3 days ago85% |
A.I.dvisor indicates that over the last year, FMED has been closely correlated with ISRG. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if FMED jumps, then ISRG could also see price increases.
Ticker / NAME | Correlation To FMED | 1D Price Change % | ||
---|---|---|---|---|
FMED | 100% | +0.26% | ||
ISRG - FMED | 67% Closely correlated | +1.48% | ||
DHR - FMED | 67% Closely correlated | +1.32% | ||
BSX - FMED | 64% Loosely correlated | -0.07% | ||
TECH - FMED | 64% Loosely correlated | +0.53% | ||
SYK - FMED | 63% Loosely correlated | +1.73% | ||
More |
A.I.dvisor indicates that over the last year, IBB has been closely correlated with IDYA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if IBB jumps, then IDYA could also see price increases.
Ticker / NAME | Correlation To IBB | 1D Price Change % | ||
---|---|---|---|---|
IBB | 100% | +0.05% | ||
IDYA - IBB | 69% Closely correlated | -1.33% | ||
KRYS - IBB | 69% Closely correlated | -1.59% | ||
DNLI - IBB | 67% Closely correlated | -4.47% | ||
SYRE - IBB | 66% Closely correlated | +1.08% | ||
ROIV - IBB | 65% Loosely correlated | N/A | ||
More |